Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 19, 2023

SELL
$233.08 - $265.59 $433,528 - $493,997
-1,860 Reduced 7.4%
23,278 $5.78 Million
Q2 2023

Jul 14, 2023

BUY
$224.99 - $256.14 $870,036 - $990,493
3,867 Added 18.18%
25,138 $6.03 Million
Q1 2023

May 08, 2023

BUY
$239.75 - $277.0 $1.24 Million - $1.43 Million
5,174 Added 32.14%
21,271 $5.36 Million
Q4 2022

Jan 19, 2023

SELL
$241.42 - $282.29 $2 Million - $2.34 Million
-8,283 Reduced 33.97%
16,097 $4.27 Million
Q3 2022

Oct 27, 2022

SELL
$247.06 - $1507.4 $5.01 Million - $30.6 Million
-20,275 Reduced 45.4%
24,380 $6.19 Million
Q2 2022

Aug 04, 2022

BUY
$237.11 - $299.66 $3.42 Million - $4.32 Million
14,408 Added 47.63%
44,655 $11.3 Million
Q1 2022

May 05, 2022

BUY
$257.27 - $315.76 $7.78 Million - $9.55 Million
30,247 New
30,247 $8.87 Million

Others Institutions Holding DHR

About DANAHER CORP


  • Ticker DHR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 727,963,008
  • Market Cap $177B
  • Description
  • Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...
More about DHR
Track This Portfolio

Track Ams Capital Ltda Portfolio

Follow Ams Capital Ltda and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ams Capital Ltda, based on Form 13F filings with the SEC.

News

Stay updated on Ams Capital Ltda with notifications on news.